THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EUROPE EDITION)

Transcription

1 THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EUROPE EDITION) Feedback from 797 patient groups in Europe PUBLISHED APRIL 2016

2 The perception [of pharma] has changed in the last years, associating more to research. National patient group in Spain specialising in mental health in 2016, patientview is publishing 20 corporate reputation of pharma reports, analysing the results from the 1,075 patient groups responding to the 2015 survey. speciality reports: cancer I circulatory conditions I diabetes I hiv/aids I hepatitis I neurological conditions I mental health I respiratory conditions I skin conditions I rare diseases (10 reports) geographic-region reports (in addition to this current europe report): eastern europe I germany I global I italy I latin america I nordic I spain I uk I usa (10 reports)

3 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID PATIENT GROUPS IN EUROPE SAY ABOUT PHARMA IN 2015? Summary of the industry-wide finding in Europe Page 3 A FEW COMMENTS ON THE EUROPEAN CORPORATE RANKINGS Page 5 WHAT CAN PHARMA COMPANIES DO TO IMPROVE THEIR CORPORATE REPUTATION? Page 6 COMMENTS FROM PATIENT GROUPS IN EUROPE, 2015 Page 7 CASE STUDY: PATIENT-GROUP RELATIONS AND PATIENT CENTRICITY AT... AbbVie Eisai Janssen EMEA (pharmaceutical companies of Johnson & Johnson) Sanofi Page 16 Page 18 Page 21 Page 24 METHODOLOGY OF THE PATIENT-GROUP SURVEY Page 27 QUESTIONNAIRE FOR PHARMA COMPANIES 2015 Page 28 APPENDIX 1: Data on how patient groups in Europe see the pharmaceutical industry in 2015, and in 2014 Page 29 APPENDIX 2: Rankings of the 45 pharma companies for each of the 6 indicators of corporate reputation, as perceived by patient groups in Europe in 2015, compared with 2014 Page 34 APPENDIX 3: Profiles of the 45 companies Page 43 APPENDIX 4: Profiles of the 797 respondent patient groups Page 90

4 LIST OF TABLES AND CHARTS BASED ON THE VIEWS OF PATIENT GROUPS IN EUROPE Percentage of patient groups in Europe claiming familiarity with the company Page 2 Percentage of patient groups in Europe claiming familiarity, and which also worked with the company Page 2 % of patient groups (by geographic region) stating that pharma is Excellent or Good at fair pricing Page 4 Rising stars in Europe 2015 (companies that have risen up the ranks 2015 v 2014, or lead the ranks in 2015) Page 5 If a pharma company wishes to improve its corporate reputation with patients and patient groups, which single strategy from the list below do you think would be MOST IMPORTANT for the company to follow? Please select only ONE option How do you think your organisation s members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2015? How do you think your organisation s members (or the people you represent) would rate the corporate reputation of the pharma industry in 2015? Page 6 Page 30 Page 30 What do you think has happened to the corporate reputation of the pharma industry over the past five years? Page 31 How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)? How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)? (Year-on-year comparators: Europe 2015, Europe 2014, and global 2015) Companies with the most effective patient-centred strategy (rankings of 45 companies, 2015; rankings of 34 companies, 2014) Companies providing the best high-quality patient information (rankings of 45 companies, 2015; rankings of 34 companies, 2014) Companies with the best record on patient safety (rankings of 45 companies, 2015; rankings of 34 companies, 2014) Companies with the most-useful high-quality products (rankings of 45 companies, 2015; rankings of 34 companies, 2014) Companies with the best record of transparency (rankings of 45 companies, 2015; rankings of 34 companies, 2014) Page 32 Page 33 Page 35 Page 36 Page 37 Page 38 Page 39 Companies with the best record on integrity (rankings of 45 companies, 2015; rankings of 34 companies, 2014) Page 40 Rankings of the 45 pharmaceutical companies in 2015, ALPHABETIC ORDER Page 41 Rankings of the 45 pharmaceutical companies in 2015, HIGHEST TO LOWEST Page 42

5 LIST OF TABLES AND CHARTS CONTINUED AbbVie page 45 Actavis page 46 Allergan page 47 Almirall page 48 Amgen page 49 Astellas page 50 AstraZeneca page 51 Baxalta page 52 Bayer page 53 Biogen Idec page 54 Boehringer Ingelheim page 55 B-MS page 56 Celgene page 57 Chiesi page 58 Eisai page 59 Eli Lilly page 60 Ferring page 61 Gedeon Richter page 62 Gilead Sciences page 63 Grünenthal page 64 GSK page 65 Hospira page 66 Ipsen page 67 Janssen page 68 LEO Pharma page 69 Lundbeck page 70 Menarini page 71 Merck & Co (US) page 72 Merck KGaA (Germany) page 73 Mylan page 74 Novartis page 75 Novo Nordisk page 76 Octapharma page 77 Otsuka page 78 Pfizer page 79 Roche page 80 Sandoz page 81 Sanofi page 82 Servier page 83 Shire page 84 Stada Arzneimittel page 85 Takeda page 86 Teva page 87 UCB page 88 ViiV Healthcare page 89 profiles of the 45 companies, according to the patient groups in europe familiar with these companies or have worked with them Each profile contains... company background information Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. = increase in revenue over the previous year or = decrease in revenue. The profiled company s main treatment subject areas (and areas of R&D). A mission statement from the profiled company. how the company has performed at six indicators of corporate reputation The profiled company s performance at the six indicators of corporate reputation in 2015, according to the patient groups in Europe familiar with the company. The profiled company s performance at the six indicators of corporate reputation, according to the patient groups in Europe that have worked with the company. How the profiled company performed in Europe for different therapy areas, compared with the company s averages in Europe across all therapy areas in How the profiled company performed in Europe for different countries/regions, compared with the company s averages in Europe in how the company ranks for corporate reputation compared with other companies The profiled company s rankings in Europe in 2015 for the six indicators of corporate reputation, compared with 44 other companies The profiled company s rankings worldwide in 2015 for the six indicators of corporate reputation, compared with 44 other companies profile of the patient groups familiar with the company Other companies that partner with a significant number of the profiled company s partner patient groups. The therapy areas and countries of the patient groups familiar with the profiled company. Janssen Pharmaceutical Companies of Johnson & Johnson

6 Contact details PatientView Registered office: One Fleet Place, London, EC4M 7WS, UK Tel: +44-(0) Registered in England, number: Data protection registration number: Z VAT registration number: GB Copyright 2016 PatientView Ltd. All rights reserved. This booklet is the property of PatientView, and no part may be reproduced without permission, or passed on to any third party without the permission of PatientView.